Severe Immune Thrombocytopenia (ITP)
Definition
Severe Immune Thrombocytopenia (ITP) is an autoimmune disorder characterized by:
- A platelet count typically < 30,000/µL (often used clinically for “severe” disease)
-
Clinically significant bleeding, such as:
- Mucosal hemorrhages (e.g., nosebleeds, gum bleeding)
- Petechiae (small red spots on the skin)
In ITP, the immune system produces antibodies that destroy platelets, increasing the risk of serious internal bleeding.
Clinical Features
Common Symptoms
Mucosal bleeding
Petechiae
Purpura (easy bruising)
---------------------------------------------------------
Additional Patient-Reported Symptoms
- Fatigue
- Memory and concentration difficulties
These non-bleeding symptoms can significantly impact quality of life, highlighting the need for holistic treatment approaches.
Risks and Complications
Patients with severe ITP are at risk of:
- Spontaneous hematomas
- Severe gastrointestinal bleeding
- Intracranial hemorrhage (life-threatening brain bleeding)
Diagnosis of Thrombocytopenia
Definition of Thrombocytopenia
Thrombocytopenia is defined as:
- Platelet count < 150,000/µL
Underlying Mechanisms
- Reduced platelet production (thrombopoiesis)
- Increased platelet destruction (e.g., autoimmune causes like ITP)
If all blood cell lines are reduced:
- Decreased erythropoiesis (red cells)
- Decreased leukopoiesis (white cells)
- Decreased thrombopoiesis (platelets)
→ This suggests a broader bone marrow or hematopoietic disorder.
Classification of ITP by Duration
- Acute ITP: < 3 months
- Persistent ITP: 3–12 months
- Chronic ITP: > 12 months
Refractory Severe ITP
- Does not respond to standard treatments
- May persist even after splenectomy
Treatment of Severe ITP
Due to bleeding risk, urgent treatment is required, typically including:
- Corticosteroids
- Intravenous immunoglobulin (IVIG)
- Other immunosuppressive therapies
Treatment goals:
- Prevent bleeding
- Increase platelet count
- Improve quality of life
Acquired vs. Inherited Thrombocytopenia
Acquired Thrombocytopenia
-
Develops due to external factors:
- Autoimmune diseases (e.g., ITP)
- Medications
- Infections
Inherited Thrombocytopenia
- Genetic condition present at birth
- Often features large platelets (macrothrombocytopenia)
- Can be misdiagnosed as ITP
Misdiagnosis may lead to unnecessary immunosuppressive treatment
Drug-Induced Thrombocytopenia
Certain medications can cause low platelet counts. These include:
- Some antibiotics
- Heparin
- Antiepileptic drugs
- Chemotherapy agents
Dietary Considerations in Thrombocytopenia
To reduce bleeding risk, patients may be advised to avoid or limit:
Foods/Substances That May Affect Platelets
- Alcohol
- Quinine (found in tonic water)
- Garlic
- Onions
- Ginger
- Turmeric
Other Dietary Factors
- Processed foods
- High-sugar items
- Trans fats
Some foods rich in antioxidants (e.g., blueberries, red grapes) may influence platelet function, though evidence is limited.
Key Takeaways
- Severe ITP involves very low platelet counts and active bleeding risk
- It is an autoimmune condition requiring prompt treatment
- Diagnosis requires distinguishing it from other causes of thrombocytopenia
- Management should address both bleeding symptoms and quality of life
References:
Immune Thrombocytopenia https://www.ncbi.nlm.nih.gov/books/NBK562282/
When you
have ITP, the immune system is out of balance in more ways than one
https://www.wayrilz.com/us/what-is-itp
Refractory
severe idiopathic thrombocytopenia and treatment challenges
https://pmc.ncbi.nlm.nih.gov/articles/PMC10129162/
Thrombocytopenia https://www.youtube.com/watch?v=i_c8x7TiHN0
Immune thrombocytopenia (ITP)
https://www.rarediseaseadvisor.com/hcp-resource/immune-thrombocytopenia-diet-nutrition/
Definition der ITP (German)
https://pro.campus.sanofi/de/immunthrombozytopenie-itp/wissen/itp-definition
Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021;96(2):188-198.
© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9
Comments
Post a Comment